Literature DB >> 16298423

2-Phenylethylamine in combination with l-deprenyl lowers the striatal level of dopamine and prolongs the duration of the stereotypy in mice.

Junichi Kitanaka1, Nobue Kitanaka, Tomohiro Tatsuta, Motohiko Takemura.   

Abstract

2-Phenylethylamine (PEA)-induced stereotypy in rodents is suggested to model psychotic symptoms of schizophrenia. It is reported that PEA induces dopamine release in the striatum in vivo and in vitro. The present study analyzed the PEA-induced stereotypy and possible associated brain dopamine metabolism in mice. Using male ICR mice treated with a combination of PEA (100 mg/kg, i.p.) and increasing doses of l-deprenyl (0-10 mg/kg, s.c.), we examined (1) the behavioral profile of stereotypy (rating the scores), and (2) the tissue levels of dopamine and its metabolites by high-performance liquid chromatography. The stereotypic scores reached a plateau level at 10 min which lasted until 30 min after a single administration of 100 mg/kg PEA. The stereotyped behavior completely disappeared 45 min after PEA administration. Pretreatment with l-deprenyl (0.1, 1, and 10 mg/kg, s.c.) dose-dependently prolonged the duration of PEA-induced stereotypy. Notably, pretreatment with l-deprenyl dose-dependently increased the continuous sniffing. Treatment with PEA in combination of l-deprenyl (1 and 10 mg/kg) significantly reduced the level of dopamine in the region of the striatum and nucleus accumbens, compared with control animals. These results suggest that PEA in combination with l-deprenyl prolonged the duration of the stereotypy (particularly, continuous sniffing) while reducing the striatal level of dopamine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16298423     DOI: 10.1016/j.pbb.2005.10.004

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  4 in total

1.  Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.

Authors:  J Kitanaka; N Kitanaka; T Tatsuta; F S Hall; G R Uhl; K Tanaka; N Nishiyama; Y Morita; M Takemura
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

2.  Lobeline attenuates methamphetamine-induced stereotypy in adolescent mice.

Authors:  Tomohiro Tatsuta; Nobue Kitanaka; Junichi Kitanaka; Yoshio Morita; Motohiko Takemura
Journal:  Neurochem Res       Date:  2006-10-20       Impact factor: 3.996

3.  BL-1023 improves behavior and neuronal survival in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice.

Authors:  J A L Hutter-Saunders; L M Kosloski; J M McMillan; N Yotam; T Rinat; R L Mosley; H E Gendelman
Journal:  Neuroscience       Date:  2011-02-12       Impact factor: 3.590

4.  Cytotoxicological analysis of a gp120 binding aptamer with cross-clade human immunodeficiency virus type 1 entry inhibition properties: comparison to conventional antiretrovirals.

Authors:  Walter Rangel Lopes de Campos; Dayaneethie Coopusamy; Lynn Morris; Bongani M Mayosi; Makobetsa Khati
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.